Emmanuel Sumithran Gnanamanickam

Emmanuel Sumithran Gnanamanickam

Auto-generated profile, based on publicly available information

Emmanuel Sumithran Gnanamanickam

Adelaide University, Adelaide, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2018 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Open access
PDF file
EGEmmanuel S. Gnanamanickam
Emmanuel S. Gnanamanickam
SDSuzanne M. Dyer
Suzanne M. Dyer
RMRachel Milte
Rachel Milte
SHStephanie L. Harrison
Stephanie L. Harrison
Enwu LiuEnwu Liu
Enwu Liu
MCMaria Crotty
Maria Crotty
Objectives: This analysis estimates the whole‐of‐system direct costs for people living with dementia in residential care by using a broad health and social care provision perspective and compares it to people without dementia living in residential care.Methods: Data were collected from 541 individuals living permanently in 17 care facilities across Australia. The annual cost of health and residential care was determined by using individual resource use data and reported by the dementia status of the individuals.Results: The average annual whole‐of‐system cost for people living with dementia in residential care was approximately AU$88 000 (US$ 67 100) per person in 2016. The cost of residential care constituted 93% of the total costs. The direct health care costs were comprised mainly of hospital admissions (48%), pharmaceuticals (31%) and out‐of‐hospital attendances (15%). While total costs were not significantly different between those with and without dementia, the cost of residential care was significantly higher and the cost of health care was significantly lower for people living with dementia.Conclusion: This study provides the first estimate of the whole‐of‐system costs of providing health and residential care for people living with dementia in residential aged care in Australia using individual level health and social care data. This predominantly bottom‐up cost estimate indicates the high cost associated with caring for people with dementia living permanently in residential care, which is underestimated when limited cost perspectives or top‐down, population costing approaches are taken.

11 September 2017 in Australian Dental Journal
Verified
Journal Article
Closed access
PDF file
EGEmmanuel Gnanamanickam
Emmanuel Gnanamanickam
DTDana Teusner
Dana Teusner
PAPeter Arrow
Peter Arrow
DBDavid S. Brennan
David S. Brennan

1 November 2019 in Child Abuse & Neglect
Verified
Journal Article
Closed access
LSLeonie Segal
Leonie Segal
HNHa Nguyen
Ha Nguyen
MMMahayaudin M. Mansor
Mahayaudin M. Mansor
EGEmmanuel Gnanamanickam
Emmanuel Gnanamanickam
JDJames Doidge
James Doidge
JAJason M. Armfield
Jason M. Armfield

13 March 2020 in Child Maltreatment
Verified
Journal Article
Closed access
PDF file
JAJason M. Armfield
Jason M. Armfield
EGEmmanuel Gnanamanickam
Emmanuel Gnanamanickam
HNHa T. Nguyen
Ha T. Nguyen
JDJames C. Doidge
James C. Doidge
DBDerek S. Brown
Derek S. Brown
LSLeonie Segal
Leonie Segal
Greater school absenteeism is associated with numerous negative educational outcomes. We used a retrospective cohort design with linked administrative data on 296,422 children to examine the relationship between school absenteeism and child protection system (CPS) involvement. Children with substantiated maltreatment had 4.1 times more unexplained and problem absences than children with no CPS involvement. In multivariate analyses, children with substantiated maltreatment had significantly greater “chronic” truancy (OR = 3.41) and less “acceptable” levels of absences (OR = 0.74) compared to children with no CPS involvement. Greater absenteeism was seen for children with substantiated neglect and who had their first CPS notification earlier in life. Being in out-of-home care for 3+ years was a protective factor for children who had a CPS notification before age 5. Additional adversities had a strong additive effect with CPS involvement on absenteeism and chronic truancy. This study demonstrates the potential scope for reducing problem absenteeism and helps inform the public debate regarding how the type and timing of CPS involvement might ameliorate or exacerbate harm for children.

1 January 2022 in Child Abuse & Neglect
Verified
Journal Article
Closed access
EGEmmanuel S. Gnanamanickam
Emmanuel S. Gnanamanickam
HNHa Nguyen
Ha Nguyen
JAJason M. Armfield
Jason M. Armfield
JDJames C. Doidge
James C. Doidge
DBDerek S. Brown
Derek S. Brown
LSLeonie Segal
Leonie Segal

1 October 2024 in The Bone & Joint Journal
Verified
Journal Article
Closed access
PDF file
AHAaron S. Hammat
Aaron S. Hammat
RNRenjy Nelson
Renjy Nelson
JDJoshua S Davis
Joshua S Davis
LMLaurens Manning
Laurens Manning
DCDavid Campbell
David Campbell
Stuart Adam CallaryStuart Adam Callary
Stuart Adam Callary
Aims: Our aim was to estimate the total costs of all hospitalizations for treating periprosthetic joint infection (PJI) by main management strategy within 24 months post-diagnosis using activity-based costing. Additionally, we investigated the influence of individual PJI treatment pathways on hospital costs within the first 24 months.Methods: Using admission and procedure data from a prospective observational cohort in Australia and New Zealand, Australian Refined Diagnosis Related Groups were assigned to each admitted patient episode of care for activity-based costing estimates of 273 hip PJI patients and 377 knee PJI patients. Costs were aggregated at 24 months post-diagnosis, and are presented in Australian dollars.Results: The mean cost per hip and knee PJI patient was $64,585 (SD $53,550). Single-stage revision mean costs were $67,029 (SD $47,116) and $80,063 (SD $42,438) for hip and knee, respectively. Two-stage revision costs were $113,226 (SD $66,724) and $122,425 (SD $60,874) for hip and knee, respectively. Debridement, antibiotics, and implant retention in hips and knees mean costs were $53,537 (SD$ 39,342) and $48,463 (SD $33,179), respectively. Suppressive antibiotic therapy without surgical management mean costs were $20,296 (SD $8,875) for hip patients and $16,481 (SD $6,712) for knee patients. Hip patients had 16 different treatment pathways and knee patients had 18 treatment pathways. Additional treatment, episodes of care, and length of stay contributed to substantially increased costs up to a maximum of $369,948.Conclusion: Treating PJI incurs a substantial cost burden, which is substantially influenced by management strategy. With an annual PJI incidence of 3,900, the cost burden would be in excess of $250 million to the Australian healthcare system. Treatment pathways with additional surgery, more episodes of care, and a longer length of stay substantially increase the associated hospital costs. Prospectively monitoring individual patient treatment pathways beyond initial management is important when quantifying PJI treatment cost. Our study highlights the importance of optimizing initial surgical treatment, and informs treating hospitals of the resources required to provide care for PJI patients.Cite this article: Bone Joint J 2024;106-B(10):1084–1092.